Monoclonal antibody against podocalyx-like protein precursor subtype 2 functionally expressed on the surface of gastric cancer cells and its preparation method and use
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ιζ’ η
- Publication Date
- 2018-10-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of biopharmaceuticals, in particular to a monoclonal antibody (named MS17-38) against the functional expression of procalyx-like protein subtype 2 (PODXL-v2) on the surface of gastric cancer cells and its preparation method and use. Background technique
[0002] As the inventor Lu Meisheng et al. previously applied for the patent "anti-cell surface ectopically expressed monoclonal antibody MS17-57 and its preparation method and use" (patent application number: 201310090565.9, published and approved), Gastric cancer (GC) is the most common malignant tumor of the digestive system in humans and one of the leading causes of tumor-related death. Countries such as China and Japan have the highest incidence rate of gastric cancer in the world, with nearly 600,000 to 700,000 new cases each year, accounting for the majority of the world's cases. Many patients with gastric cancer are already in the late clinical stage...